Latest Insider Transactions at Sema4 Holdings Corp. (SMFR)
This section provides a real-time view of insider transactions for Sema4 Holdings Corp. (SMFR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sema4 Holdings Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sema4 Holdings Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,728
-11.68%
|
$283,328
$76.75 P/Share
|
|
Dec 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,197
+18.39%
|
-
|
|
Dec 16
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,501
-12.86%
|
$798,076
$76.75 P/Share
|
|
Dec 16
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+18.68%
|
-
|
|
Dec 09
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,661
-5.5%
|
$278,236
$76.37 P/Share
|
|
Dec 09
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,547
+8.96%
|
-
|
|
Dec 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,137
-4.4%
|
$86,412
$76.37 P/Share
|
|
Dec 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,462
+8.69%
|
-
|
|
Dec 02
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
263
-1.11%
|
$20,514
$78.39 P/Share
|
|
Dec 01
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
718
+2.94%
|
-
|
|
Nov 22
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,981
-11.28%
|
$758,556
$76.38 P/Share
|
|
Nov 21
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,019
-4.92%
|
$865,368
$72.34 P/Share
|
|
Nov 20
2024
|
Jason Ryan |
SELL
Open market or private sale
|
Indirect |
15,490
-63.58%
|
$1,068,810
$69.57 P/Share
|
|
Nov 19
2024
|
Jason Ryan |
SELL
Open market or private sale
|
Indirect |
31,510
-25.93%
|
$2,237,210
$71.49 P/Share
|
|
Nov 19
2024
|
Jason Ryan |
SELL
Bona fide gift
|
Indirect |
141,356
-75.05%
|
-
|
|
Nov 18
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
126,782
-4.45%
|
$8,874,740
$70.78 P/Share
|
|
Nov 18
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,307
-5.05%
|
$1,539,183
$69.4 P/Share
|
|
Nov 15
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
20,359
-0.71%
|
$1,404,771
$69.78 P/Share
|
|
Nov 15
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,108
-3.44%
|
$1,640,668
$71.65 P/Share
|
|
Oct 31
2024
|
School Of Medicine At Mount Sinai Icahn |
SELL
Open market or private sale
|
Direct |
865,800
-23.2%
|
$64,935,000
$75.0 P/Share
|
|
Oct 29
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,154
-2.0%
|
$142,164
$66.6 P/Share
|
|
Oct 29
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+3.48%
|
-
|
|
Oct 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
274
-0.61%
|
$18,084
$66.6 P/Share
|
|
Oct 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
753
+1.64%
|
-
|
|
Oct 15
2024
|
Jason Ryan |
BUY
Exercise of conversion of derivative security
|
Direct |
130
+0.18%
|
-
|
|
Oct 15
2024
|
Joshua Ruch |
BUY
Exercise of conversion of derivative security
|
Direct |
130
+1.6%
|
-
|
|
Sep 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,635
-5.59%
|
$97,495
$37.59 P/Share
|
|
Sep 16
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,197
+13.25%
|
-
|
|
Sep 16
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,501
-9.19%
|
$388,537
$37.59 P/Share
|
|
Sep 16
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+14.1%
|
-
|
|
Sep 09
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,639
-3.67%
|
$120,087
$33.33 P/Share
|
|
Sep 09
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,546
+6.2%
|
-
|
|
Sep 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
895
-2.19%
|
$29,535
$33.33 P/Share
|
|
Sep 09
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,462
+5.69%
|
-
|
|
Sep 03
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
262
-0.68%
|
$8,122
$31.71 P/Share
|
|
Sep 01
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
717
+1.82%
|
-
|
|
Aug 19
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
50,000
-1.85%
|
$1,700,000
$34.49 P/Share
|
|
Aug 16
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
50,000
-1.82%
|
$1,700,000
$34.3 P/Share
|
|
Aug 15
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
39,824
-1.43%
|
$1,314,192
$33.08 P/Share
|
|
Aug 13
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
24,987
-0.89%
|
$849,558
$34.76 P/Share
|
|
Aug 12
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
59,787
-2.08%
|
$1,972,971
$33.95 P/Share
|
|
Aug 08
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
100,000
-3.37%
|
$3,100,000
$31.82 P/Share
|
|
Aug 06
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
12,994
-0.44%
|
$376,826
$29.35 P/Share
|
|
Aug 01
2024
|
Casdin Capital, LLC Director |
BUY
Other acquisition or disposition
|
Direct |
413,655
+10.55%
|
$13,236,960
$32.25 P/Share
|
|
Jul 31
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
88,839
-2.89%
|
$2,931,687
$33.5 P/Share
|
|
Jul 29
2024
|
Opko Health, Inc. |
SELL
Open market or private sale
|
Direct |
50,000
-1.6%
|
$1,650,000
$33.86 P/Share
|
|
Jul 29
2024
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,154
-2.27%
|
$71,082
$33.54 P/Share
|
|
Jul 29
2024
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+3.93%
|
-
|
|
Jul 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
274
-0.72%
|
$9,042
$33.54 P/Share
|
|
Jul 29
2024
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
753
+1.94%
|
-
|